ClinicalTrials.Veeva

Menu

Postpartum Screening of Type 2 Diabetes (Tot ou tard)

U

Université de Sherbrooke

Status

Completed

Conditions

Type 2 Diabetes

Treatments

Procedure: oral glucose tolerance test 2 days post-partum

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Gestational diabetes mellitus (GDM) complicates 5 to 30 % of pregnancies. GDM is defined as hyperglycemia with onset or first recognition during pregnancy. Because it is a forerunner of type 2 diabetes mellitus (T2DM), professional associations recommend T2DM postpartum screening (T2DM-pPS) at 6 weeks/6 months post delivery, using a 75g oral glucose tolerance test (OGTT).

However, less than a quarter of these women are screened. This recommendation has failed for multiple reasons; the most important being that busy new mothers must deal with the major inconveniences of returning to a sampling center for a 2h testing session, bringing baby along or paying for a sitter, transportation, parking... A mother-friendly solution is direly needed.

The investigators hypothesize that, in these women, results of an OGTT performed after delivery on the last day of their hospital stay (OGTT-1) will predict results of the recommended OGTT (OGTT-2) at 6 weeks/6 months postpartum.

The main aim of our project is to determine the optimal cut-off value for the 2h glucose result during OGTT-1 in order to predict abnormal glucose tolerance status at OGTT-2 (the gold standard), in the same woman.

Enrollment

121 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women aged between 18 and 45 years;
  • Having a positive diagnosis of gestational diabetes mellitus (IADPSG criteria);
  • Treated with diet or insulin;
  • Have given birth to a child at term; gestational age > 37 weeks;
  • Have been followed during her pregnancy by a physician who delivers in CHUS;
  • Have signed the consent form.

Exclusion criteria

  • History of glucose intolerance or diabetes before the pregnancy;

  • Have presented another obstetrical pathology during the pregnancy;

    • Severe gestational high blood pressure with proteinuria;
    • Delayed intrauterine development syndrome;
    • Pregnancy with more than a foetus;
    • Drug addiction;
    • Had complications during the delivery such as:
  • Moderate to severe postpartum bleeding;

  • Surgery in postpartum (curettage, hysterectomy, etc.).

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

121 participants in 1 patient group

postpartum screening
Experimental group
Description:
Oral glucose tolerance test 2 days post-partum
Treatment:
Procedure: oral glucose tolerance test 2 days post-partum

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems